FDA Approves Sanofi's New Therapy for Bleeding Disorders
(Reuters) -The U.S. Food and Drug Administration approved French drugmaker Sanofi's therapy, paving the way for a new type of treatment for patients 12 years of age and older with a rare disorder that prevents blood from clotting properly, the regulator said on Friday.
(Reporting by Padmanabhan Ananthan and Sriparna Roy in Bengaluru; Editing by Shailesh Kuber)
